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Celiac  disease  is an  immune-mediated  disorder  triggered  by  gluten  in genetically  susceptible  persons.
Despite  its detrimental  effects  on  human  health,  it has  not  disappeared  over  time. The  current  evolution-
ary  theory  is  that  celiac  disease  is  more  common  in  areas  reached  later  by agricultural  revolution  than  in
countries  that started  consumption  of wheat  earlier,  due  to negative  selection  caused  by  celiac disease.
We  reviewed  data  on worldwide  prevalence  of  celiac  disease,  wheat  consumption,  and  frequencies  of
HLA-celiac-disease-predisposing-genotypes  to investigate  their  mutual  relationship.  Studies  assessing
prevalence  of  celiac  disease  were  identiﬁed  through  a MEDLINE  search.  Wheat consumption  and  fre-
quencies  of  HLA-DQ2-DQ8  were  obtained  from  Food  and  Agriculture  Organization  of  the  United  Nations
and  allelefrequencies.net  database.  Correlations  between  celiac  disease,  wheat  consumption,  and  HLA
were  analyzed  by  linear  regression.  We  observed  a signiﬁcant  correlation  between  wheat  consump-
tion  and HLA  DQ2  (p = 0.01)  and  the  sum  of DQ2  and  DQ8  (p  =  0.01)  frequencies.  Wheat  consumption  and
HLA-DQ2  tend  to co-localize  in  different  continents.  The  correlation  between  the  prevalence  of celiac dis-
ease  and  either  DQ2  and/or  DQ8, or the  product  of  DQ2  + DQ8*wheat  consumption  was  not  statistically
signiﬁcant.
Co-localization  of  gluten  consumption  and  HLA-celiac-disease-predisposing-genotypes  can  be
explained  by  positive  selection  of  HLA-DQ2  genes  in  wheat-consuming  areas,  and “demic  diffusion”  of
Middle  East  farmers  into  Europe.
© 2014  Editrice  Gastroenterologica  Italiana  S.r.l.  Published  by  Elsevier  Ltd.  
Open access under CC BY-NC-ND license.. Introduction
Celiac disease (CD) is a systemic immune-mediated disorder
riggered by dietary gluten in genetically susceptible persons,
esulting from the interplay between environmental and genetic
actors. The major component of the genetic predisposition,
xplaining about 40% of it, depends on some HLA-related class II
enes: most CD patients are HLA-DQ2 positive (90%), while half of
he remaining 10% are HLA-DQ8 positive. As concerns the environ-
ental factors, the ingestion of gliadin and glutenin fractions of
heat gluten and similar alcohol-soluble proteins in other grains
∗ Corresponding author at: Department of Pediatrics, University of Catania, Via
. Soﬁa 78, 90124 Catania, Italy. Tel.: +39 095 378 17 82; fax: +39 095 378 23 85;
obile:  +39 320 11 25 476.
E-mail  address: elenalionetti@inwind.it (E. Lionetti).
ttp://dx.doi.org/10.1016/j.dld.2014.08.002
590-8658/© 2014 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. Op(rye and barley) triggers the development of the celiac enteropathy,
as well as other disease manifestations [1–3].
In the past, CD was  considered a rare disorder mostly affect-
ing individuals of European origin. In 1978, Simoons formulated
a theory on the evolutionary history of the disease. He postu-
lated that the spreading of wheat consumption from the so-called
“Fertile Crescent” in the Middle East along the Mediterranean coun-
tries to northern Europe exerted a negative selective pressure on
genes predisposing to CD. The higher frequency of the HLA-B8
allele (at that time the only gene known to be associated with CD)
and the resulting higher frequency of CD in north-western Europe
were attributed to a lack of exposure to cereals until recent times
[4].
The Simoons’ theory did not survive the new era of CD genet-
ics and epidemiology. The HLA-B8 was  spuriously associated with
CD, basically due to linkage disequilibrium with the HLA-DQ2,
the “true” CD-predisposing genotype. At the same time, serolog-
ical screening studies showed that (a) CD is one the commonest
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ifelong disorders, affecting around 1% of the population world-
ide and (b) CD is a common disorder in both north-western and
outh-eastern Europe despite some inter-country variability [5,6].
espite its negative effects on human health, the CD phenotype
as not disappeared over time, but is even increasing nowadays
n areas with high level of both gluten consumption and CD-
redisposing HLA-genotypes (so-called “evolutionary paradox of
D”) [7–9].
The  analysis of (a) the geographical distribution of genes that
redispose to CD, (b) wheat consumption and (c) CD prevalence, can
elp to understand the evolutionary history of this multi-factorial
isorder. To this aim, in the present study we reviewed the data on
orldwide prevalence of CD, wheat consumption, and frequencies
f HLA DQ2 and DQ8 haplotypes. We  combined the three geograph-
cal maps to investigate their mutual relationship.
. Methods
.1. Protocol
Before review we developed a protocol, including eligibility
riteria, search strategies, criteria for study selection, methods for
xtracting related data, and methods for assessing study quality
nd statistical methodology.
.2.  Information sources, eligibility criteria, search, and study
election
The  current worldwide distribution of CD, wheat consumption
nd frequency of HLA DQ2 and DQ8 haplotypes were the focus of
ur search.
Studies on the prevalence of CD were identiﬁed by searching
lectronic databases and scanning reference lists of articles, and by
onsultation with experts in the ﬁeld. The search was applied to
he Medline database using PubMed by combining search terms
or prevalence (prevalence, epidemiology) with keywords for CD
or coeliac disease, coeliac, gluten intolerance). As far as the diag-
ostic algorithm, we included only studies deﬁning CD as either
a) CD positive serology plus typical small intestinal biopsy ﬁnd-
ngs (Marsh 3a-3c) or (b) CD positive serology (high level of IgA
nti-transglutaminase and/or antiendomysial antibodies). All types
f study design (e.g. cross-sectional, cohort, case–control, and
ase series), except case reports, were considered for inclusion in
his review. Search results were limited to studies based on the
creening of unselected (low-risk) child and adult samples. Studies
n healthy blood donors were excluded because they differed from
he general population in social, health-related, and gender vari-
bles. No publication date or publication status restrictions were
mposed. Eligibility assessment of studies was performed indepen-
ently in an unblinded standardized manner by the two  authors.
isagreements between reviewers were resolved by consensus.
ll studies described in this review were published between 1950
start of Medline) and August 2012.
Worldwide distribution data of wheat consumption levels were
btained from the Food and Agriculture Organization of the
nited Nations (FAO) database (http://www.fao.org). The dura-
ion  of wheat culture was taken from the work of Ammerman and
avalli-Sforza [10]. According to the duration of wheat consump-
ion we divided the Middle-East and European countries into four
roups from 1 (gluten-containing cereals introduced around 10,000
ears ago) to 4 (gluten-containing cereals introduced 6000–4000
ears ago). The frequency of HLA-DQ2 and HLA-DQ8 in differ-
nt countries were obtained by the allelefrequencies.net database
http://www.allelefrequencies.net) [11].er Disease 46 (2014) 1057–1063
2.3. Data collection process
We  developed a data extraction sheet (based on the Cochrane
Consumers and Communication Review Group’s data extraction
template) [12], pilot tested it on three randomly selected included
studies, and reﬁned it accordingly. One author (E.L.) extracted the
data from included studies, and the second author (C.C.) checked
the extracted data.
2.4.  Data items
Regarding the prevalence of CD, from each included study infor-
mation was extracted on (1) study design; (2) characteristics of
participants, including number, age, setting of enrolment, method
of diagnosis of CD; and (3) prevalence of CD.
To evaluate the worldwide distribution of genes predisposing
to CD we extracted the frequency of the allele DQB1*02 (DQ2),
and the frequency of the haplotype DQA1*0301/DQB1*0302 (DQ8)
from the allelefrequencies.net database. DQB1*02 positivity is the
hallmark of the different CD-predisposing DQ2 haplo/genotypes,
that is DQA1*05/DQB1*02 in trans or cis position (DQ2.5) and
DQA1*02/DQB1*02 (DQ2.2).
To evaluate the worldwide wheat consumption we extracted
data on wheat availability in the year 2009 for each country
(expressed in grams per capita/day) from the FAO database.
2.5.  Risk of bias
To  ascertain the validity of the eligible studies, the study design,
the size and representativeness of the study population (i.e. the
presence of selection bias), the validity of outcomes (risk of con-
founding or bias), and the quality of the statistical analysis were
taken into account. We  assessed the methodological quality of
included studies in accordance with the guidelines of the Cochrane
Consumers and Communication Review Group, adapted for the cur-
rent review concerning observational non-intervention studies. In
all cases, the two  authors independently assessed the quality of the
studies included, with any disagreements resolved by discussion
and consensus. Where necessary, study authors were contacted for
additional information or for clariﬁcation of the study methods.
2.6.  Statistical analysis
We  calculated the prevalence of CD, the levels of wheat con-
sumption, and the frequencies of HLA-DQ2 and HLA-DQ8 for
different regions of the world. In case of multiple studies in the same
country we calculated the weighted average. For each parameter
we constructed a geographical map.
The correlations were studied by Spearman’s correlation test
and associations were further studied by multivariate linear regres-
sion analysis.
All  differences were considered to be statistically signiﬁcant at
a 5% probability level.
Data  were analyzed with SPSS 13.0 software (SPSS, Chicago, IL).
3. Results
3.1. Study selection and characteristics (CD prevalence)
Supplemental Figure 1 shows the ﬂow diagram of study selec-
tion of studies on the prevalence of CD. Table 1 summarizes the
studies reporting on the prevalence of CD [13–43]. Thirty-one pub-
lications were included, containing 38 CD prevalence estimates,
of which 23 in children and 15 in adults, across 24 countries. The
included studies involved 122,858 participants. None but one of the
articles reported a power calculation to determine the population
sample size.
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Table  1
Summary of included studies evaluating the prevalence of celiac disease in different countries.
Country and reference Setting Population Diagnosis* Prevalence: n (%)
Algeria [13] Healthy population Children (2–15 yrs) 3 56/989 (5.6)
Argentine  [14] Screening pre-nuptial Adults 2 12/2000 (0.6)
Australia  [15] Healthy population Adults 2 12/3011 (0.4)
Brazil  [16] Care center Children (1–14 yrs) 1 11/2034 (0.5)
Burkina  Faso [17] Healthy population Adults 3 0/600 (0)
Egypt  [18] Healthy population Children (7 mths–18 yrs) 2 8/1500 (0.5)
Finland  [19]
Finland [20]
School
Healthy  population
Children  (7–16 yrs)
Adults
2
1
37/3654  (1.0)
113/4846 (2.4)
Germany  [20] Healthy population Adults 1 8/3098 (0.2)
India  [21]
India [22]
School
Care  center
Children  (3–17 yrs)
Children  (6–12 mths)
1
1
14/4347 (0.3)
4/400  (1.0)
Iran  [23]
Iran [24]
Iran [25]
Healthy  population
Healthy population
School
Adults
Adults
Children  (13 yrs)
1
1
1
27/2799 (1.0)
7/1440  (0.5)
3/634  (0.5)
Ireland  [26] Healthy population Adults 1 15/1823 (0.8)
Italy  [27]
Italy  [20]
Italy  [20]
School
School
Healthy  population
Children
Children  (10–19 yrs)
Adults
1
1
1
30/3188  (0.9)
31/2645 (1.1)
32/4781 (0.7)
Libya  [28] School Children (5–17 yrs) 1 19/2920 (0.8)
Netherlands  [29] Healthy population Children (2–4 yrs) 2 31/6127 (0.5)
New  Zealand [30] Healthy population Adults 2 12/1064 (1.2)
Portugal  [31] School Children (15 yrs) 1 4/536 (0.7)
Russia  [32] School  Children (6–14 yrs) 1 4/1988 (0.2)
Spain  [33]
Spain [34]
Spain [34]
Children  from birth
Care  center
Care center
Children  (3 yrs)
Children  (1–14 yrs)
Adults
1
1
1
7/830  (0.8)
11/780 (1.4)
10/3450 (0.3)
Sweden  [35]
Sweden [36]
Healthy  population
Care  center
Adults
Children  (2.5 yrs)
2
1
10/1894 (0.5)
9/690  (1.3)
Sweden  [37]
Tunisia  [38]
School
School
Children  (12 yrs)
Children  (6–12 yrs)
1
3
212/7274 (2.9)
42/6286  (0.6)
Turkey  [39]
Turkey [40]
School
School
Children  (6 mths–17 yrs)
Children  (6–17 yrs)
1
3
7/1263 (0.6)
215/20190 (1.0)
United Kingdom [41]
United  Kingdom [42]
United  Kingdom [20]
United  Kingdom [20]
General practice
Healthy population
Healthy population
Healthy population
Adults
Children  (7 yrs)
Children  (12–15 yrs)
Adults
1
3
1
1
85/7550  (1.1)
54/5470 (1.0)
17/1975 (0.9)
69/4656 (1.5)
USA  [43]
USA [43]
School
Healthy  population
Children  (6–18 yrs)
Adults
1
1
4/1281  (0.3)
27/2845 (0.9)
Total  1269/122858 (1.0)
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c* Diagnosis of celiac disease was deﬁned as: 1 = serology positive for celiac dis
 = serology positive for celiac disease (anti-endomisium antibodies antibodies) and
.2. Geo-epidemiology of CD
Overall, the worldwide prevalence of CD among low-risk (gen-
ral population) adults and children ranged from 0 to 5.6%, with a
ean prevalence ratio of 1% (Supplemental Figure S2). In Europe
he overall prevalence of CD was 1%, with large variations between
ountries [20]. Similar rates have been reported from the US popu-
ation (0.9%) [42], from many South American countries [14,16],
nd from developed countries mostly populated by individuals
f European origin, e.g., Australia (0.4%) and New Zealand (1.1%)
15,30]. In areas of the developing world, rates overlapping Euro-
ean ﬁgures, especially in North Africa (i.e., 0.5% in Egypt, 0.8%
n Libya, and 0.6% in Tunisia) [17,27,37], Middle East (i.e., 0.8% in
ran and 1% in Turkey) [23–25,39,40], and India (i.e., 0.4%) [21,22]
ere found. The Saharawi population of Arab-Berber origin liv-
ng in Algeria had the highest prevalence of CD (5.6%) among all
orld populations [13]. In Burkina Faso, wheat consumption is
lmost negligible, and the prevalence of CD was null [17]. No CD
revalence studies were found from China or other Far Eastern
ountries.
.3. Wheat consumptionData  on wheat consumption were available for 150 countries.
n general, wheat consumption ranged between 21 and 564 g per
apita/day (mean = 260) (Supplemental Figure S3).anti-transglutaminase antibodies) and histology compatible with celiac disease;
logy compatible with celiac disaese; 3 = anti-endomisium antibodies positives.
3.4.  HLA-DQ2 and DQ8 frequency
Data on HLA-DQ were available for 28 (DQ2) and 15 (DQ8)
countries, respectively. Frequencies of HLA DQ2  and DQ8 ranged
between 0 and 28% (mean = 14) and between 1 and 9% (mean = 4),
respectively (Supplemental Figures S4 and S5).
3.5. CD prevalence, wheat consumption and HLA-DQ2 and–DQ8
frequency
The  prevalence of CD and the frequency of DQ2 or DQ8 or DQ2
plus DQ8 were not signiﬁcantly correlated (Rho = 0.4, p = 0.07;
Rho = 0.3, p = 0.4). Likewise, there was  no signiﬁcant correlation
between the nationwide prevalence of CD and the level of wheat
consumption (Rho = 0.4, p = 0.06), and between the prevalence of
CD and the product of DQ2 + DQ8 frequency * wheat consump-
tion (Rho = 0.3, p = 0.3). On the other hand, a highly signiﬁcant
correlation between wheat consumption and the frequency of
either HLA DQ2 (Fig. 1) or the sum of DQ2 and DQ8 (Fig. 2) was
found. There was a trend of positive correlation between wheat
consumption and HLA-DQ8 frequency, although this did not reach
statistical signiﬁcance (Rho = 0.5, p = 0.06). A signiﬁcant correlation
between the frequency of HLA DQ2 and the duration of wheat
consumption according to the pattern of wheat culture spreading
was found (Fig. 3). In the same four areas, the duration of wheat
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Fig. 1. Correlation between the level of wheat consumption and the frequency of
HLA-DQ2 in different countries of the world.
Fig. 2. Correlation between the level of wheat consumption and the sum of the
frequencies of HLA DQ2 and DQ8 in different countries around the world.
Fig. 3. Correlation between the frequency of HLA DQ2 and the duration of
wheat  consumption in four different areas of Middle East and Europe. Countries
are  grouped according to the duration of wheat consumption from 1 (gluten-
containing  cereals introduced around 10,000 years ago) to 4 (gluten-containing
cereals  introduced 6000–4000 years ago). 1: Turkey, Iran, Israel; 2: Tunisia, Italy,
Greece; 3: Germany; 4: Sweden, Finland, Ireland.
Fig. 4. Correlation between the current level of wheat consumption and the dura-
tion of wheat consumption in four different areas of Middle East and Europe.
Countries  are grouped according to the duration of wheat consumption from
1  (gluten-containing cereals introduced around 10,000 years ago) to 4 (gluten-
containing  cereals introduced 6000–4000 years ago). 1: Turkey, Iran, Israel; 2:
Tunisia, Italy, Greece; 3: Germany; 4: Sweden, Finland, Ireland.
consumption was  signiﬁcantly correlated with the level of current
wheat consumption (Fig. 4).
A detailed analysis of within-continent distribution showed
that gluten and HLA-DQ2 co-segregated not only in Europe/Middle
East, but also in other Continents. In India wheat consumption is
higher in Northern-Western states such as Punjab, Haryana, Delhi,
Rajasthan, Uttar Pradesh, Bihar and Madhya Pradesh (so-called
“celiac belt”). Likewise, the DQ2 allele frequency is higher in North
(31.9%) than in South India (12.78% for Piramalai Kallars and 9% for
Yadavas) [44]. In Africa the frequency of DQ2 is higher in the North-
ern populations consuming a gluten-rich diet, such as Saharawi
(39%) [45], Libya (34%) [46], Algeria (28.3%) [11], Tunisia (23.4%)
[11], Morocco (25%) [11], than sub-Saharan populations showing
low frequency of DQ2 (Rwanda 15.5%, Tanzania 13.5%, Cameroon
7%) [11] and low level of wheat consumption. The frequency of
the DQB1*0201 allele is higher in the northern Chinese than in the
southern Chinese populations, and the consumption of wheat in
the northern area is higher than in the southern area, where rice is
the staple diet [47].
The  multivariable linear regression analysis did not show any
signiﬁcant effect of predisposing genes and wheat consumption on
the prevalence of CD.
4.  Discussion
Our study shows that CD is a common condition in different
continents, including many developing areas, with a mean preva-
lence of 0.9% worldwide. We  did not ﬁnd a signiﬁcant correlation
between the prevalence of CD and predisposing HLA genes, a
ﬁnding that can be explained, at least in part, by a certain degree of
data heterogeneity. For example, the Australian and New Zealand
HLA-DQ allele frequencies derived from individuals of Aboriginal
and Maori origin, while studies in the same countries on CD preva-
lence were performed in individuals of prominently European
origin. Although a trend of positive correlation between the preva-
lence of CD and the level of wheat consumption was  identiﬁed,
this also did not reach statistical signiﬁcance, probably due to
non-linear correlation between the level of gluten intake and the
risk of CD development. A dose–effect relationship between gluten
intake and development of CD has been previously shown, but
only at very low gluten intakes (ranging between 50 and 500 mg
of daily gluten) [48]. Although the worldwide variation of wheat
E. Lionetti, C. Catassi / Digestive and Liv
Fig. 5. The chain of events eventually leading to the current high prevalence of
celiac disease: (1) increasing gluten intake in the early era of the agriculture rev-
olution in Middle East and then Europe; (2) increased prevalence of HLA-DQ2 due
to demic population diffusion and/or positive selection caused by adverse effects of
wheat consumption on health, e.g. dental caries; (3) in modern time, e.g. the last
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YA,  kiloyear (thousand years); CD, Celiac disease.
onsumption is high, the current intake is well above 500 mg  per
ay in most countries, therefore minimizing the effect that the
evel of gluten intake may  have on the prevalence of CD.
The  analysis of correlation between wheat consumption,
LA-DQ2  and DQ8 frequency and CD prevalence had already
een performed by Abadie and coworkers in their recent review
aper [49]. However our work took this analysis a step forward
nd showed a previously unreported strong correlation between
he geographical distribution of HLA CD-predisposing genotypes
nd wheat consumption. The paradoxical distribution of these
wo CD-causative factors is best exempliﬁed by ﬁndings in the
urope/Middle East area. Domestication of gluten-containing
ereals (particularly ancient varieties of wheat and barley) began
pproximately 10,000 years ago in Neolithic settlements in the
orth-eastern (Turkey, Iran, and Iraq) and in the south-western
Palestine, Syria, and Lebanon) regions of the so-called “Fertile Cres-
ent” area. Cultivation of wheat and barley slowly spread northwest
ard across Europe to reach Western countries, as Britain, “only”
000 years ago [10]. The agriculture revolution paved the way  to
ew diseases, such as CD. Since treatment with the gluten-free
iet was not available in the ancient time, the CD geno/phenotype
xerted a negative impact on human reproductive ﬁtness and sur-
ival over thousand years. As a consequence of a prolonged negative
elective pressure, CD and its predisposing genotypes should be
ess common in Middle East than in European countries (as orig-
nally theorized by Simoons) [4]. On the contrary, nowadays CD is
qually common in UK and Turkey, and the frequency of HLA-DQ2
the major CD-predisposing haplotype) is even higher in Turkey
nd Iran, i.e. countries consuming more wheat and for a longer
uration of time, than in Finland and Ireland, i.e. countries consum-
ng less gluten and for a shorter duration of time. This “evolutionary
eliac paradox” is strengthened by the co-localization of gluten
onsumption and HLA-DQ2 we found in other areas of the world,
.g. Africa and India. To explain these counterintuitive ﬁndings, we
uggest that the diffusion of HLA CD-predisposing genotypes and
he diffusion of CD occurred in different times (Fig. 5). The currently
igh prevalence of CD is most likely a recent event, explained
y recent changes in environmental conditions, e.g. related to
he quantity and quality of ingested gluten, dough fermentation,
uman intestinal microbioma and pattern of infant nutrition [7,50].
On the other hand, the parallel geographical distribution of
luten intake and HLA-DQ2 and DQ8 genotypes could be explained
y different mechanisms, which are not mutually exclusive:
(a)  a founder effect reﬂecting higher prevalence of DQ2/DQ8
in  the early farmers that 10,000 years ago spread fromer Disease 46 (2014) 1057–1063 1061
Middle East and gradually colonized Europe determining a
South/East–North/West genetic gradient (so called “demic dif-
fusion”  model of Cavalli-Sforza and Ammerman) between
Middle East and Europe [10] (local effect). This slow “wave
of  advance” of a population of early farmers with a high fre-
quency  of DQ2 and DQ8 could lead to progressive dilution of
their  genetic background by mixing with the local European
populations;
(b) a positive selection of HLA CD-predisposing genotypes pushed
by  protection against deleterious conditions driven by the agri-
cultural  revolution (worldwide effect). An extensive search
of  the literature showed that only one disease is partially
“protected” by an HLA-DQ, CD-predisposing haplotype (DQ2),
that  is dental caries. A recent Brazilian study showed that ado-
lescents  positive for HLA-DQ2 allele were less likely to have
dental  caries than their counterparts who  were negative for this
allele  (OR = 0.33, CI 0.16–0.66) [51]. Nothing was found about
disease  protection induced by the HLA-DQ8 haplotype.
Dental caries is the typical Neolithic disease that dramatically
increased after wheat carbohydrates acquired a primary role in
human diet [52]. Interestingly, also CD patients show a reduced
prevalence of dental caries when compared to controls, despite
high incidence of dental enamel hypoplasia [53]. Streptococcus
mutans, the principal agent responsible for oral fermentation of
sugars leading to dental caries, is less abundant in the intestinal
mucosa of CD children, regardless of inﬂammatory status [54]. The
consumption of wheat is positively correlated to the development
of dental caries whereas rice, the typical gluten-free cereal, shows
less cariogenic potential [55]. In the context of the ancestral wheat-
consuming society, when cure and prevention of dental caries
were basically non-existent, some sort of genetically determined
resistance to dental caries could well drive a positive selection of
HLA-DQ2. It remains to be elucidated how DQ2 positivity protects
from dental caries development, e.g. by accelerating the clear-
ance of “sticky” (and possibly cariogenic) gluten peptides from the
mouth and teeth surface. The DQ2-dental caries protection hypoth-
esis needs to ﬁnd conﬁrmation by further population studies.
Our  (b) explanation is more generalizable than (a), and could
explain the high gluten/high DQ2 co-localization in different,
apparently unrelated, areas of the world such as Europe, Africa and
India. Thus, the highest prevalence of DQ2 among wheat consuming
populations could be another example of evolutionary adaptation
driven by the dietary changes imposed by the agricultural revolu-
tion, in analogy to lactase persistence in milk drinking populations
[56] and glucose-6-phosphate deﬁciency (G6PD) in Mediterranean
populations consuming broad beans [57]. In this context CD could
simply represent the modern “dark side” of a genetic structure
(DQ2 positivity) conferring resistance to a negative consequence
of a wheat-based diet.
We  are aware of the limitations of our geo-epidemiological
analysis:  (a) current wheat consumption does not perfectly reﬂect
historical wheat consumption (although both historical consider-
ation and our data suggest that a strong correlation does indeed
exist); (b) FAO data reﬂect individual availability of wheat (includ-
ing unconsumed leftover) instead of individual wheat intake; (c)
heterogeneity of HLA data does not allow to differentiate high-risk
(e.g. double copy of the DQB1*02 gene) from lower risk genotypes;
(d) CD prevalence data are based on different diagnostic methods
and different age groups; (e) regional differences in the consump-
tion of CD-triggering grains different from wheat (rye and barley)
have not been investigated; (f) the possible evolutionary role
of non-HLA predisposing genes has not been evaluated. At least
39 non-HLA CD predisposing genes have been identiﬁed, most
of them inﬂuencing the inﬂammatory and immune pathways.
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ecent studies showed consistent signs of positive selection for
D-associated non HLA alleles, i.e. IL12A, IL18RAP, and SH2B3 [58].
In conclusion, we suggest that the current high prevalence
f CD is the last link in a chain of events started about 10,000
ears ago after wheat domestication and diffusion from the Mid-
le East. To explain the so-called “evolutionary celiac paradox” of
o-localization of gluten consumption and HLA CD predisposing
enotypes, we suggest a primary role for positive selection of
he major CD-predisposing haplotype, that is HLA-DQ2, in wheat-
onsuming populations. The force driving HLA-DQ2 selection could
ave been protection against dental caries, a disease causing a
remendous negative impact on the health and reproductive ﬁtness
f ancient populations. The “DQ2-dental caries protection” hypoth-
sis needs to ﬁnd conﬁrmation by further population studies.
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